Evolent Health A Aktie
3,42
EUR
-0,06
EUR
-1,72
%
3,97
USD
-0,14
USD
-3,41
%
Werbung
Evolent Health A Aktie Analyse
| 01.06.17 | Evolent Health A Outperform | Robert W. Baird & Co. Incorporated | |
| 13.07.16 | Evolent Health A Outperform | FBR Capital | |
| 29.03.16 | Evolent Health A Outperform | FBR Capital | |
| 06.01.16 | Evolent Health A Buy | Canaccord Adams |
Werbung
Werbung